Early detection and innovative biologic treatment can prevent hospitalizations, improve quality of life, and extend the ...

To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report ...

Mid Yorkshire Teaching NHS Trust has become the first site in Europe to recruit a patient to a major international clinical ...

COPD research needs to increase focus on rural health disparities and consider the impact of sociocultural and environmental exposures on health outcomes, according to a new perspective in the ...

Patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a critical role in helping patients understand their ...

New research reveals that women have roughly 50% greater risk of developing chronic obstructive pulmonary disease (COPD) compared to men, even when accounting for smoking history and other risk ...

Temple Health leads research showing how women and non-smokers face rising risks, and how new treatments are changing the future of care ...

FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, ...

The diagnosis of chronic obstructive pulmonary disease, or COPD, is improved by incorporating CT lung imaging and respiratory symptoms. This fresh, multidimensional approach better identifies patients ...

Philadelphia, April 30, 2025 – Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive ...

Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung ...

Recent research suggests that certain biologic medications called monoclonal antibodies may help treat emphysema more effectively than some current therapies. These medications include benralizumab ...